ACTRN12615000492550
Recruiting
未知
In patients with COPD, what are the patterns of use of Tiotropium at the time of an admission to hospital.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Chronic Obstructive Pulmonary Disease
- Sponsor
- Medical Research Institute of New Zealand
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •i.Admitted to hospital with an AECOPD.
- •ii.Prescribed Tiotropium at the time of admission.
- •iii.Greater than or equal to 40 years of age on admission
Exclusion Criteria
- •i.Patients unwilling to complete the questionnaire(s).
- •ii.Patients in whom Tiotropium has been commenced during this admission.
- •iii.Patients who do not have the capacity to give full written informed consent to participate in the study (as judged by the investigator).
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Characteristics of patients with COPD newly treated with fluticasone/umeclidinium/vilanterol, budesonide/glycopyrronium/formoterol, or multiple inhaler triple therapy in the Medical Data Vision, Inc. clinical databaseCOPDJPRN-jRCT1030210229Akiyama Shoko3,500
Not yet recruiting
Not Applicable
Characterisation of ambulatory COPD patients with long-term oxygen therapyJ44.8Other specified chronic obstructive pulmonary diseaseDRKS00027874ungenklinik Köln MerheimKliniken der Stadt KoelnUniversität Witten/Herdecke40
Completed
Not Applicable
Phenotype classification of COPDCOPDJPRN-UMIN000021013Tokyo Medical and Dental University90
Recruiting
Not Applicable
Development of COPD patients cohortDiseases of th respiratory systemKCT0002129Asan Medical Center1,000
Not yet recruiting
Not Applicable
Individual characteristics of COPD patients. Analysis of subtypes based on Western and Chinese diagnostics.Chronic Obstructive Pulmonary DiseaseCOPD10006436NL-OMON55103ouis Bolk Instituut75